EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 35 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349,650 | -8.2% | 43,761 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $380,721 | +195.9% | 43,761 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $128,657 | -60.7% | 43,761 | -53.2% | 0.00% | -50.0% |
| Q4 2022 | $327,012 | +75.8% | 93,432 | +230.3% | 0.00% | 0.0% |
| Q4 2020 | $186,000 | – | 28,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $33,150,000 | 13.70% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,233,597 | $25,578,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 303,396 | $2,400,000 | 1.03% |
| Samsara BioCapital, LLC | 480,000 | $3,797,000 | 0.88% |
| Altium Capital Management LP | 224,541 | $1,776,000 | 0.65% |
| Monashee Investment Management LLC | 220,000 | $1,740,000 | 0.64% |
| RA Capital Management | 3,370,506 | $26,660,000 | 0.57% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 341,974 | $2,705,000 | 0.43% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 108,285 | $857,000 | 0.29% |
| Orbimed Advisors | 970,860 | $7,680,000 | 0.14% |